ASTRIA THERAPEUTICS INC's ticker is and the CUSIP is 04635X102. A total of 62 filers reported holding ASTRIA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,043 | +362.6% | 3,357 | +416.5% | 0.00% | – |
| Q2 2023 | $5,414 | +9925.9% | 650 | -82.1% | 0.00% | -100.0% |
| Q4 2022 | $54 | -99.2% | 3,626 | +357.3% | 0.00% | – |
| Q3 2022 | $7,000 | +16.7% | 793 | -61.7% | 0.00% | – |
| Q2 2022 | $6,000 | +100.0% | 2,073 | +409.3% | 0.00% | – |
| Q1 2022 | $3,000 | -72.7% | 407 | -79.2% | 0.00% | – |
| Q4 2021 | $11,000 | – | 1,958 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 911,736 | $8,060,000 | 2.93% |
| VR Adviser, LLC | 538,999 | $4,765,000 | 0.61% |
| COMMODORE CAPITAL LP | 239,270 | $2,115,000 | 0.56% |
| Perceptive Advisors | 1,959,652 | $17,323,000 | 0.25% |
| Cormorant Asset Management, LP | 552,903 | $4,888,000 | 0.20% |
| RA Capital Management | 1,262,193 | $11,158,000 | 0.16% |
| Soleus Capital Management, L.P. | 112,499 | $994,000 | 0.16% |
| ArchPoint Investors | 28,247 | $250,000 | 0.08% |
| Ikarian Capital, LLC | 87,580 | $775,000 | 0.06% |
| Old Well Partners, LLC | 12,116 | $107,000 | 0.06% |